Base de dados : LILACS
Pesquisa : D09.947.875.359.448 [Categoria DeCS]
Referências encontradas : 803 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 81 ir para página                         

  1 / 803 LILACS  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: lil-233914
Autor: Barboza, Ruy.
Título: Modelo linear-por-partes da membrana da célula pancreática ß / Piecewise linear model of pancreatic ß cells membrane
Fonte: In: Schiabel, Homero; Slaets, Annie France Frère; Costa, Luciano da Fontoura; Baffa Filho, Oswaldo; Marques, Paulo Mazzoncini de Azevedo. Anais do III Fórum Nacional de Ciência e Tecnologia em Saúde. Säo Carlos, s.n, 1996. p.652-652, ilus, graf.
Idioma: pt.
Conferência: Apresentado em: Fórum Nacional de Ciência e Tecnologia em Saúde, 3 e Congresso Brasileiro de Engenharia Biomédica, 15 e Congresso Brasileiro de Físicos em Medicina , 6 e Congresso Brasileiro de Informática em Saúde, 5 e Encontro Brasileiro de Proteçäo Radiológica, Campos do Jordäo, 13-17 out. 1996.
Resumo: Um sistema de três equações diferenciais contendo apenas relações lineares e funções lineares-por-partes é apresentado como modelo para descrever o comportamento oscilatório das células Beta do pâncreas. As equações foram obtidas através de simplificação sistemática do modelo mais rigoroso de Chay.
Descritores: Modelos Lineares
Ilhotas Pancreáticas
-Cálcio
Glucose
Axônios
Potássio
Responsável: BR1.1 - BIREME
BR1.1/3012.106


  2 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-730626
Autor: Cardoso, Maria Vera Lúcia Moreira Leitão; Farias, Leiliane Martins; Melo, Gleicia Martins de.
Título: Music and 25% glucose pain relief for the premature infant: a randomized clinical trial / Música e glicose 25% no alívio da dor dos prematuros: ensaio clínico randomizado / Música y glucosa al 25% en el alivio del dolor de los prematuros: ensayo clínico aleatorio
Fonte: Rev. latinoam. enferm. (Online);22(5):810-818, Sep-Oct.2014. tab.
Idioma: en.
Projeto: CNPq.
Resumo: OBJECTIVE: to analyze the total Premature Infant Pain Profile scores of premature infants undergoing arterial puncture during music and 25% glucose interventions, and to assess their association with neonatal and therapeutic variables. METHOD: a randomized clinical trial with 80 premature infants; 24 in the Experimental Group 1 (music), 33 in the Experimental Group 2 (music and 25% glucose), 23 in the Positive Control Group (25% glucose). All premature infants were videotaped and a lullaby was played for ten minutes before puncture in Experimental Groups 1 and 2; 25% glucose administered in Experimental Group 2 and the Positive Control Group two minutes before puncture. RESULTS: 60.0% of premature infants had moderate or maximum pain; pain scores and intervention groups were not statistically significant. Statistically significant variables: Experimental Group 1: head and chest circumference, Apgar scores, corrected gestational age; Experimental Group 2: chest circumference, Apgar scores, oxygen therapy; Positive Control group: birth weight, head circumference. CONCLUSION: neonatal variables are associated with pain in premature infants. Brazilian Registry of Clinical Trials: UTN: U1111-1123-4821. .

OBJETIVO: analisar os escores totais do Premature Infant Pain Profile dos prematuros submetidos a punção arterial sob intervenção da música e glicose 25%, verificar a associação desses com variáveis neonatais e terapêuticas. MÉTODO: ensaio clínico randomizado com 80 prematuros, 24 Grupo Experimental 1 (música), 33 Grupo Experimental 2 (música e glicose 25%), 23 Grupo Controle Positivo (glicose 25%). Todos os prematuros foram filmados e uma música de ninar foi ouvida por 10 minutos antes da punção no Grupo Experimental 1 e Grupo Experimental 2, glicose 25% administrada no Grupo Experimental 2 e Grupo Controle Positivo dois minutos antes da punção. RESULTADOS: 60,0% dos prematuros apresentaram dor moderada ou intensa, os escores de dor e grupos de intervenção não demonstraram significância estatística. Variáveis estatisticamente significantes, Grupo Experimental 1: perímetro cefálico e torácico, Apgar, idade gestacional corrigida; Grupo Experimental 2: perímetro torácico, Apgar, oxigenoterapia; Grupo Controle Positivo: peso nascimento, perímetro cefálico. CONCLUSÃO: variáveis neonatais apresentam associação com dor em prematuros. Registro Brasileiro de Ensaio Clínico: UTN: U1111-1123-4821. .

OBJETIVO: analizar los puntajes totales del Premature Infant Pain Profile de los prematuros sometidos a punción arterial bajo intervención de música y de glucosa al 25%, y verificar la asociación de estos con variables neonatales y terapéuticas. MÉTODO: ensayo clínico aleatorio con 80 prematuros: 24 Grupo Experimental 1 (música), 33 Grupo Experimental 2 (música y glucosa al 25%) y 23 Grupo Control Positivo (glucosa al 25%). Todos los prematuros fueron filmados y una canción de cuna fue escuchada por 10 minutos antes de la punción en el Grupo Experimental 1 y en el Grupo Experimental 2, glucosa al 25% administrada en el Grupo Experimental 2 y en el Grupo Control Positivo, dos minutos antes de la punción. RESULTADOS: 60,0% de los prematuros presentaron dolor moderado o intenso, los puntajes de dolor y los grupos de intervención no demostraron ser estadísticamente significativos. Las variables estadísticamente significativas fueron en el Grupo Experimental 1: perímetro cefálico y torácico, Apgar, Edad Gestacional corregida; en el Grupo Experimental 2: perímetro torácico, Apgar, oxigenoterapia; y, en el Grupo Control Positivo: peso nacimiento, perímetro cefálico. CONCLUSIÓN: las variables neonatales presentan una asociación con el dolor en prematuros. Registro Brasileño de Ensayo Clínico: UTN: U1111-1123-4821. .
Descritores: Manejo da Dor/métodos
Glucose/administração & dosagem
Musicoterapia
-Recém-Nascido Prematuro
Método Duplo-Cego
Limites: Seres Humanos
Masculino
Feminino
Recém-Nascido
Tipo de Publ: Research Support, Non-U.S. Gov't
Ensaio Clínico Controlado Aleatório
Responsável: BR1.1 - BIREME


  3 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1022118
Autor: Silva Lemões, Juliana; Lemons e Silva, Claudia Fernanda; Farias Avila, Sabrina Peres; Scherrer Montero, Cândida Raquel; Anjos e Silva, Sérgio Delmar dos; Samios, Dimitrios; Ruaro Peralba, Maria do Carmo.
Título: Chemical pretreatment of Arundo donax L. for second-generation ethanol production
Fonte: Electron. j. biotechnol;31:67-54, Jan. 2018. ilus, tab, graf.
Idioma: en.
Projeto: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Resumo: Background: Pretreatment of lignocellulosic biomass is essential for using it as a raw material for chemical and biofuel production. This study evaluates the effects of variables in the chemical pretreatment of the Arundo biomass on the glucose and xylose concentrations in the final enzymatic hydrolysate. Three pretreatments were tested: acid pretreatment, acid pretreatment followed by alkaline pretreatment, and alkaline pretreatment. Results: The amounts of glucose and xylose released by the enzymatic hydrolysis of the Arundo biomass obtained from acid pretreatment ranged from 6.2 to 19.1 g/L and 1.8 to 3.1 g/L, respectively. The addition of alkaline pretreatment led to a higher yield from the enzymatic hydrolysis, with the average glucose concentration 3.5 times that obtained after biomass hydrolysis with an acid pretreatment exclusively. The use of an alkaline pretreatment alone resulted in glucose and xylose concentrations similar to those obtained in the two-step pretreatment: acid pretreatment followed by alkaline pretreatment. There was no significant difference in 5-hydroxymethylfurfural, furfural, or acetic acid concentrations among the pretreatments. Conclusion: Alkaline pretreatment was essential for obtaining high concentrations of glucose and xylose. The application of an alkaline pretreatment alone resulted in high glucose and xylose concentrations. This result is very significant as it allows a cost reduction by eliminating one step.
Descritores: Etanol/metabolismo
Poaceae/química
-Ácidos/química
Xilose/análise
Celulose/química
Biomassa
Biocombustíveis
Glucose/análise
Hidrólise
Lignina
Responsável: CL1.1 - Biblioteca Central


  4 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1022044
Autor: Revin, Victor; Atykyan, Nelli; Lyovina, Ekaterina; Dragunova, Yuliya; Ushkina, Victoriya.
Título: Effect of ultraviolet radiation on physiological and biochemical properties of yeast Saccharomyces cerevisiae during fermentation of ultradispersed starch raw material
Fonte: Electron. j. biotechnol;31:61-66, Jan. 2018. graf, ilus, tab.
Idioma: en.
Projeto: Ministry of Education and Science of the Russian Federation.
Resumo: Background: Study of correlation between pretreatment of yeast with ultraviolet radiation and efficiency of further fermentation of wort made of ultrafine grain particles to ethanol. Results: We investigated three races of industrial yeast Saccharomyces cerevisiae (native and irradiated by ultraviolet). Physiological properties during fermentation of starchy wort were tested in all variants. It was shown that activation of the yeast by ultraviolet radiation allows to further increase the ethanol yield by 25% on average compared with the native yeast races when using thin (up to micro- and nano-sized particles) or standard grain grinding. Conclusions: Using mechanical two-stage grinding of starchy raw materials and ultraviolet pretreatment of yeast, the efficiency of saccharification of starch and fermentation of wort to ethanol was increased.
Descritores: Saccharomyces cerevisiae/efeitos da radiação
Raios Ultravioleta
Leveduras/efeitos da radiação
Etanol/efeitos da radiação
-Saccharomyces/metabolismo
Amido
Temperatura Ambiente
Leveduras/metabolismo
Estabilidade Enzimática
Etanol/metabolismo
Fermentação
Glucose
Amilases
Responsável: CL1.1 - Biblioteca Central


  5 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: biblio-1021461
Autor: Soo, Chiu-Shyan; Yap, Wai-Sum; Hon, Wei-Min; Ramli, Norhayati; Md Shah, Umi Kalsom; Phang, Lai-Yee.
Título: Co-production of hydrogen and ethanol by Escherichia coli SS1 and its recombinant
Fonte: Electron. j. biotechnol;30:64-70, nov. 2017. ilus, graf, tab.
Idioma: en.
Projeto: Fundamental Research Grant Scheme.
Resumo: Background: The development of a potential single culture that can co-produce hydrogen and ethanol is beneficial for industrial application. Strain improvement via molecular approach was proposed on hydrogen and ethanol co-producing bacterium, Escherichia coli SS1. Thus, the effect of additional copy of native hydrogenase gene hybC on hydrogen and ethanol co-production by E. coli SS1 was investigated. Results: Both E. coli SS1 and the recombinant hybC were subjected to fermentation using 10 g/L of glycerol at initial pH 7.5. Recombinant hybC had about 2-fold higher cell growth, 5.2-fold higher glycerol consumption rate and 3-fold higher ethanol productivity in comparison to wild-type SS1. Nevertheless, wild-type SS1 reported hydrogen yield of 0.57 mol/mol glycerol and ethanol yield of 0.88 mol/mol glycerol, which were 4- and 1.4-fold higher in comparison to recombinant hybC. Glucose fermentation was also conducted for comparison study. The performance of wild-type SS1 and recombinant hybC showed relatively similar results during glucose fermentation. Additional copy of hybC gene could manipulate the glycerol metabolic pathway of E. coli SS1 under slightly alkaline condition. Conclusions: HybC could improve glycerol consumption rate and ethanol productivity of E. coli despite lower hydrogen and ethanol yields. Higher glycerol consumption rate of recombinant hybC could be an advantage for bioconversion of glycerol into biofuels. This study could serve as a useful guidance for dissecting the role of hydrogenase in glycerol metabolism and future development of effective strain for biofuels production.
Descritores: Etanol/metabolismo
Escherichia coli/metabolismo
Hidrogênio/metabolismo
Hidrogenase/metabolismo
-Recombinação Genética
Biodegradação Ambiental
Meios de Cultura
Escherichia coli/enzimologia
Alcalinização
Fermentação
Glucose/metabolismo
Glicerol/metabolismo
Hidrogenase/genética
Responsável: CL1.1 - Biblioteca Central


  6 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Texto completo
Id: biblio-951911
Autor: Razali, Nor Razida; Huri, Hasniza Zaman; Ibrahim, Luqman; Vethakkan, Shireene Ratna; Abdullah, Bashar Mudhaffar.
Título: Glycemic effects of simvastatin: Where do we stand?
Fonte: Braz. J. Pharm. Sci. (Online);54(1):e17192, 2018. tab, graf.
Idioma: en.
Projeto: University of Malaya.
Resumo: ABSTRACT In clinical practice, simvastatin is usually used in the treatment of dyslipidemia patients and those at risk of or with established cardiovascular disease. However, previous studies have shown that simvastatin has the potential to affect glycemic parameters as it reportedly reduced insulin secretion and sensitivity. The exact mechanism by which simvastatin affects glycemia is still unknown, but previous studies have postulated the involvement of the glucose-insulin secretion mechanism. This review focuses on the effects of simvastatin, either alone or in combination with other lipid lowering agents, antidiabetics and antihypertensives, on glucose homeostasis. Some studies have reported that simvastatin might impair the levels of glucose metabolism markers in the blood while others have reported no effect or improvement in glycemia.
Descritores: Sinvastatina/efeitos adversos
Interações Medicamentosas
Glucose/efeitos adversos
Antagonistas da Insulina
-Técnicas In Vitro/instrumentação
Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia
Transportador de Glucose Tipo 2
Responsável: BR40.1 - DBD - Divisão de Biblioteca e Documentacão do Conjunto das Químicas


  7 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Texto completo
Id: biblio-895556
Autor: Oliveira, Evelyn de; Vila, Laura G; Trentin, Thays de C; Jubé, Tiago de O; Martins, Danieli B.
Título: Biochemical parameters of the giant anteater (Myrmecophaga tridactyla Linnaeus, 1758) of the Brazilian Cerrado / Parâmetros bioquímicos de tamanduás-bandeiras (Myrmecophaga tridactyla Linnaeus, 1758) do cerrado brasileiro
Fonte: Pesqui. vet. bras = Braz. j. vet. res;38(1):189-194, Jan. 2018. tab.
Idioma: en.
Projeto: CNPq.
Resumo: The giant anteater (Myrmecophaga tridactyla) is classified as a vulnerable species on Brazil's list of species at risk of extinction mainly due to deforestation and forest fires. This has contributed to a considerable increase in detailed clinical case records of the treatment of wild species at veterinary institutions. However, the paucity of serum biochemical profiles of healthy giant anteaters has made it difficult to evaluate these animals, preventing diagnosis, treatment and prognosis. The objective of this work was to collect data about the biochemical profile of healthy giant anteaters from the Brazilian Cerrado raised in captivity, in order to better understand the physiological characteristics inherent to this species. Eighteen analytes from 12 healthy giant anteaters were measured. The following means and standard deviations were found in the biochemical analyses: albumin 3.29±0.33g/dL, ALT 15.49±7.98 IU/L, amylase 1037.92±149.04 IU/L, AST 21, 12±7.50 IU/L, total cholesterol 62.79±20.08mg/dL, HDL cholesterol 14.73±4.98mg/dL, LDL cholesterol 26.60±11.05mg/dL, VLDL cholesterol 2.14±1.06mg/dL, CK 111.61±70.16 IU/L, creatinine 1.05±0.37mg/dL, iron 194.64±81.17µg/dL, GGT 65.18±54.57 IU/L, glucose 103.71±29.63mg/dL, globulins 2.76±0.36g/dL, lipase 28.80±5.11 IU/L,TSP 6.05±0.56g/dL, triglycerides 10.71±5.29mg/dL, and urea 53.46±18.28mg/dL. The values found in this study can be used as references for the laboratory evaluation of giant anteaters living in conditions similar to those of this study. This is one of the first reports of biochemical examinations on giant anteaters of the Cerrado biome.(AU)

O tamanduá-bandeira (Myrmecophaga tridactyla) está classificado como espécie vulnerável na lista brasileira de espécies ameaçadas de extinção devido principalmente ao desmatamento e aos incêndios florestais. Tal fato contribuiu com o aumento da casuística de atendimento de espécies silvestres em instituições veterinárias. Porém, a escassez de valores bioquímicos séricos em tamanduás-bandeiras hígidos tem dificultado a avaliação destes animais, impedindo o diagnóstico, tratamento e prognóstico. O objetivo deste trabalho foi fornecer dados sobre o perfil bioquímico de tamanduás-bandeiras saudáveis do cerrado brasileiro, criados em cativeiro, a fim de compreender melhor as características fisiológicas inerentes a esta espécie. Foram mensurados 18 analitos de 12 tamanduás-bandeiras hígidos. As médias e o desvio padrão correspondentes às análises bioquímicas foram: albumina 3,29±0,33g/dL; ALT 15,49±7,98 UI/L; amilase 1037,92±149,04 UI/L; AST 21, 12±7,50 UI/L; colesterol total 62,79±20,08mg/dL; colesterol HDL 14,73±4,98mg/dL; colesterol LDL 26,60±11,05mg/dL; colesterol VLDL 2,14±1,06mg/dL; CK 111,61±70,16 UI/L; creatinina 1,05±0,37mg/dL; ferro 194,64±81,17µg/dL; GGT 65,18±54,57 UI/L; glicose 103,71±29,63mg/dL; globulinas 2,76±0,36g/dL; lipase 28,80±5,11 UI/L; PST 6,05±0,56g/dL; triglicerídeos 10,71±5,29mg/dL; ureia 53,46±18,28mg/dL. Os valores encontrados neste estudo podem ser utilizados como referência para a avaliação laboratorial de tamanduás-bandeiras que vivam em condições similares ao do presente estudo. Este é um dos primeiros estudos a relatar exames bioquímicos em tamanduás-bandeiras do bioma cerrado.(AU)
Descritores: Fenômenos Bioquímicos
Xenartros/sangue
Glucose/análise
Lipídeos/sangue
-Análise Química do Sangue/veterinária
Brasil
Limites: Animais
Responsável: BR68.1 - Biblioteca Virginie Buff D'Ápice


  8 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-889233
Autor: Qin, Wei; Fan, Fuqiang; Zhu, Yi; Huang, Xiaolong; Ding, Aizhong; Liu, Xiang; Dou, Junfeng.
Título: Anaerobic biodegradation of benzo(a)pyrene by a novel Cellulosimicrobium cellulans CWS2 isolated from polycyclic aromatic hydrocarbon-contaminated soil
Fonte: Braz. j. microbiol;49(2):258-268, Apr.-June 2018. graf.
Idioma: en.
Projeto: National Natural Science Foundation of China; . Fundamental Research Funds for the Central Universities.
Resumo: Abstract Cellulosimicrobium cellulans CWS2, a novel strain capable of utilizing benzo(a)pyrene (BaP) as the sole carbon and energy source under nitrate-reducing conditions, was isolated from PAH-contaminated soil. Temperature and pH significantly affected BaP biodegradation, and the strain exhibited enhanced biodegradation ability at temperatures above 30 °C and between pH 7 and 10. The highest BaP removal rate (78.8%) was observed in 13 days when the initial BaP concentration was 10 mg/L, and the strain degraded BaP at constant rate even at a higher concentration (50 mg/L). Metal exposure experimental results illustrated that Cd(II) was the only metal ion that significantly inhibited biodegradation of BaP. The addition of 0.5 and 1.0 g/L glucose enhanced BaP biodegradation, while the addition of low-molecular-weight organic acids with stronger acidity reduced BaP removal rates during co-metabolic biodegradation. The addition of phenanthrene and pyrene, which were degraded to some extent by the strain, showed no distinct effect on BaP biodegradation. Gas chromatography-mass spectrometry (GC-MS) analysis revealed that the five rings of BaP opened, producing compounds with one to four rings which were more bioavailable. Thus, the strain exhibited strong BaP degradation capability and has great potential in the remediation of BaP-/PAH-contaminated environments.
Descritores: Microbiologia do Solo
Poluentes do Solo/metabolismo
Benzo(a)pireno/metabolismo
Actinobacteria/isolamento & purificação
Actinobacteria/metabolismo
-Temperatura Ambiente
Cádmio/metabolismo
Carbono/metabolismo
Ácidos Carboxílicos/metabolismo
Biotransformação
Actinobacteria/classificação
Meios de Cultura/química
Inibidores Enzimáticos/metabolismo
Glucose/metabolismo
Concentração de Íons de Hidrogênio
Anaerobiose
Cromatografia Gasosa-Espectrometria de Massas
Responsável: BR1.1 - BIREME


  9 / 803 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-889166
Autor: Li, Yun-Cheng; Gou, Zi-Xi; Zhang, Ying; Xia, Zi-Yuan; Tang, Yue-Qin; Kida, Kenji.
Título: Inhibitor tolerance of a recombinant flocculating industrial Saccharomyces cerevisiae strain during glucose and xylose co-fermentation
Fonte: Braz. j. microbiol;48(4):791-800, Oct.-Dec. 2017. graf.
Idioma: en.
Projeto: National Natural Science Foundation of China; . Talent Project for Science and Technology Innovation of Sichuan Province.
Resumo: ABSTRACT Lignocellulose-derived inhibitors have negative effects on the ethanol fermentation capacity of Saccharomyces cerevisiae. In this study, the effects of eight typical inhibitors, including weak acids, furans, and phenols, on glucose and xylose co-fermentation of the recombinant xylose-fermenting flocculating industrial S. cerevisiae strain NAPX37 were evaluated by batch fermentation. Inhibition on glucose fermentation, not that on xylose fermentation, correlated with delayed cell growth. The weak acids and the phenols showed additive effects. The effect of inhibitors on glucose fermentation was as follows (from strongest to weakest): vanillin > phenol > syringaldehyde > 5-HMF > furfural > levulinic acid > acetic acid > formic acid. The effect of inhibitors on xylose fermentation was as follows (from strongest to weakest): phenol > vanillin > syringaldehyde > furfural > 5-HMF > formic acid > levulinic acid > acetic acid. The NAPX37 strain showed substantial tolerance to typical inhibitors and showed good fermentation characteristics, when a medium with inhibitor cocktail or rape straw hydrolysate was used. This research provides important clues for inhibitors tolerance of recombinant industrial xylose-fermenting S. cerevisiae.
Descritores: Saccharomyces cerevisiae/efeitos dos fármacos
Xilose/metabolismo
Glucose/metabolismo
-Fenóis/metabolismo
Fenóis/farmacologia
Saccharomyces cerevisiae/crescimento & desenvolvimento
Saccharomyces cerevisiae/genética
Saccharomyces cerevisiae/metabolismo
Ácidos/metabolismo
Ácidos/farmacologia
Microbiologia Industrial
Fermentação
Furanos/metabolismo
Furanos/farmacologia
Responsável: BR1.1 - BIREME


  10 / 803 LILACS  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-889144
Autor: Techaparin, Atiya; Thanonkeo, Pornthap; Klanrit, Preekamol.
Título: High-temperature ethanol production using thermotolerant yeast newly isolated from Greater Mekong Subregion
Fonte: Braz. j. microbiol;48(3):461-475, July-Sept. 2017. tab, graf.
Idioma: en.
Projeto: National Research University Project of Thailand.
Resumo: Abstract The application of high-potential thermotolerant yeasts is a key factor for successful ethanol production at high temperatures. Two hundred and thirty-four yeast isolates from Greater Mekong Subregion (GMS) countries, i.e., Thailand, The Lao People's Democratic Republic (Lao PDR) and Vietnam were obtained. Five thermotolerant yeasts, designated Saccharomyces cerevisiae KKU-VN8, KKU-VN20, and KKU-VN27, Pichia kudriavzevii KKU-TH33 and P. kudriavzevii KKU-TH43, demonstrated high temperature and ethanol tolerance levels up to 45 °C and 13% (v/v), respectively. All five strains produced higher ethanol concentrations and exhibited greater productivities and yields than the industrial strain S. cerevisiae TISTR5606 during high-temperature fermentation at 40 °C and 43 °C. S. cerevisiae KKU-VN8 demonstrated the best performance for ethanol production from glucose at 37 °C with an ethanol concentration of 72.69 g/L, a productivity of 1.59 g/L/h and a theoretical ethanol yield of 86.27%. The optimal conditions for ethanol production of S. cerevisiae KKU-VN8 from sweet sorghum juice (SSJ) at 40 °C were achieved using the Box-Behnken experimental design (BBD). The maximal ethanol concentration obtained during fermentation was 89.32 g/L, with a productivity of 2.48 g/L/h and a theoretical ethanol yield of 96.32%. Thus, the newly isolated thermotolerant S. cerevisiae KKU-VN8 exhibits a great potential for commercial-scale ethanol production in the future.
Descritores: Pichia/metabolismo
Saccharomyces cerevisiae/metabolismo
Etanol/metabolismo
-Pichia/isolamento & purificação
Pichia/genética
Pichia/química
Ásia Sudeste
Saccharomyces cerevisiae/isolamento & purificação
Saccharomyces cerevisiae/genética
Saccharomyces cerevisiae/química
Sorghum/metabolismo
Glucose/metabolismo
Temperatura Alta
Responsável: BR1.1 - BIREME



página 1 de 81 ir para página                         
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde